Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), produces modest increases in heart rate that clinicians and patients should understand
Pharmacol Therap
In animal experiments on such drugs, studies on rodents have found that the GLP-1RAs may promote the development of medullary thyroid carcinoma, but this effect has not been observed in non-human primates [23]
Coordinate supplementation with your workout schedule for maximum impact
Back Nathan, DM, Schreiber, E, Fogel, H, et al (Feb 1992) 'Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects', Journal Diabetes Care , 15/2, 270-6
